Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
Trial details
- Registry ID
- NCT05739435
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque PsoriasisNCT05739435 | ALMS | Phase 2 | Active not recruiting | 2027-12-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |